A Study of Onartuzumab (MetMAb) in Combination With mFOLFOX6 in Patients With Metastatic Human Epidermal Growth Factor Receptor 2 (HER2) Negative Gastroesophageal Cancer
Clinical trial NCT01590719 · COMPLETED
Trial details
- NCT number
- NCT01590719
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-07-01
- Primary completion
- 2014-10-01
- Enrollment
- 123
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.